Paul Morton

Principal Data Scientist
Genentech, Inc.
South San Francisco, California, United States

Presentation(s):

• PB0258 - Emicizumab and females with hemophilia A in the ATHNdataset and prospective ATHN7 study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0205 - Long-term safety and effectiveness of emicizumab in people with hemophilia A in the Hemophilia Natural History Study (ATHN 7)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT